Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06151379
Status:
COMPLETED
Last Update Posted:
2023-11-30
First Post:
2023-11-04
Brief Title:
Muscle Parameters and Pathological Response in Breast Cancer Patients
Sponsor:
Acıbadem Atunizade Hospital
Organization:
Acıbadem Atunizade Hospital
Study Overview
Official Title:
The Relation Between the Initial Value of the Skeletal Mass Index and Pathological Response
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators aimed to accurately measure muscle mass and predict pCR to NAC and its effect on clinical outcomes
Detailed Description:
In patients with operable breast cancer BC receiving neoadjuvant chemotherapy NAC the pathological response rate was found to be related to body composition The success of complete pathologic response pCR is a known prognostic factor in BC patients treated with NAC The investigators aimed to accurately measure muscle mass and predict pCR to NAC and its effect on clinical outcomes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None